Press "Enter" to skip to content

What Western Pa. doctors are saying about controversial Alzheimer's drug

In this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. The Food and Drug Administration recently approved aducanumab, or Aduhelm, the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease.

Whether the first U.S. drug intended to thwart Alzheimer’s disease signals a major milestone or “dangerous hope” depends on which Western Pennsylvania doctor you ask.


Source: The Tribune-Review

Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    %d bloggers like this: